Filing Details
- Accession Number:
- 0000899243-21-036773
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-21 16:15:08
- Reporting Period:
- 2021-09-17
- Accepted Time:
- 2021-09-21 16:15:08
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1590877 | Regenxbio Inc. | RGNX | Biological Products, (No Disgnostic Substances) (2836) | 471851754 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1652936 | M. Allan Fox | C/O Regenxbio Inc. 9804 Medical Center Drive Rockville MD 20850 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-09-17 | 48,233 | $45.04 | 1,364,309 | No | 4 | S | Indirect | By DING LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By DING LLC |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 315,000 | Indirect | By HBF Gift Trust LLC |
Common Stock | 278,541 | Indirect | By Fox 2020 Trust |
Common Stock | 315,000 | Indirect | By AMF Gift Trust LLC |
Common Stock | 722,485 | Indirect | By AMF Family Gift Trust LLC |
Footnotes
- This transaction was executed in multiple trades at prices ranging from $45.00 to $45.15. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- The reporting person disclaims beneficial ownership of such shares except to the extent of his indirect pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.